NASDAQ

Kalaris Therapeutics, Inc. (KLRS)

♥ 633 Thanks from members

Live price chart, market sentiment, and community perspectives for Kalaris Therapeutics, Inc. (NASDAQ: KLRS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Kalaris Therapeutics Scientific TeamLeadership: Chief Executive OfficerLeadership: Chief Scientific OfficerHolder: Venture Capital InvestorsHolder: Institutional Life Science FundsOphthalmic TherapeuticsRetinal Disease Pipeline Drugs#KLRS#Kalaris Therapeutics#Biotech IPO#Retinal Therapies#Ophthalmology